The Food and Drug Administration announced Wednesday that it has approved the first new influenza drug with a novel mechanism of action in nearly 20 years. The drug, Xofluza, is being brought to the U.S. market by Genentech, a division of Roche.

from https://www.scientificamerican.com/article/fda-approves-a-fast-acting-flu-drug-that-is-taken-in-a-single-dose/
https://static.scientificamerican.com/sciam/cache/file/FA930C16-CBBA-49C7-BE5F3FC8213D22F6_source.jpg?w=590&h=800&B6983B09-D291-4D8B-9FAF6D91563DD58F